Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...
Alloreactive NK cells can be delivered either as adoptive immunotherapy or within the context of hematopoietic cell transplantation (HCT). There are three methods from which NK cell products for ...
T cell-based immunotherapies including immune checkpoint blockade and chimeric antigen receptor T cells can induce durable responses in patients with cancer. However, clinical efficacy is limited due ...
The deal initially focuses on preclinical-stage immunotherapy DF-7001 ... compounds are designed to activate and direct NK and cytotoxic T cell killing against cancer cells.
3Innovative Institute of Tumor Immunity and Medicine (ITIM), Hefei, China. 4Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China. Search for other works by ...